REVANCE THERAPEUTICS INC

CUSIP: 761330109 Class: Common Stock

DCF Advisers, LLC's Holding History (CIK: 0001802493)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 19,417 Value ($000) $101 Avg Close — Range —
Q2 2024
Shares 250,000 Value ($000) $643 Avg Close — Range —
Q1 2024
Shares 263,372 Value ($000) $1,296 Avg Close — Range —
Q4 2023
Shares 256,872 Value ($000) $2,258 Avg Close — Range —
Q3 2023
Shares 26,500 Value ($000) $304 Avg Close — Range —
Q2 2022
Shares 12,000 Value ($000) $166 Avg Close — Range —